vs
柯蒂斯-莱特（CW）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是柯蒂斯-莱特的1.5倍（$1.4B vs $947.0M），瑞思迈净利率更高（27.6% vs 14.5%，领先13.1%），柯蒂斯-莱特同比增速更快（14.9% vs 11.0%），柯蒂斯-莱特自由现金流更多（$315.1M vs $311.2M），过去两年柯蒂斯-莱特的营收复合增速更高（15.2% vs 9.0%）
柯蒂斯-莱特公司是总部位于美国北卡罗来纳州戴维森的制造与服务提供商，在美国内外均设有工厂及业务网点。公司1929年由柯蒂斯、莱特及多家供应商合并成立，成立之初即为美国最大航空企业，二战期间为美军生产了超14.2万台航空发动机。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CW vs RMD — 直观对比
营收规模更大
RMD
是对方的1.5倍
$947.0M
营收增速更快
CW
高出3.9%
11.0%
净利率更高
RMD
高出13.1%
14.5%
自由现金流更多
CW
多$3.9M
$311.2M
两年增速更快
CW
近两年复合增速
9.0%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $947.0M | $1.4B |
| 净利润 | $137.0M | $392.6M |
| 毛利率 | 37.5% | 61.8% |
| 营业利润率 | 19.2% | 34.6% |
| 净利率 | 14.5% | 27.6% |
| 营收同比 | 14.9% | 11.0% |
| 净利润同比 | 16.2% | 13.9% |
| 每股收益（稀释后） | $3.69 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CWRMD
| Q4 25 | $947.0M | $1.4B | ||
| Q3 25 | $869.2M | $1.3B | ||
| Q2 25 | $876.6M | $1.3B | ||
| Q1 25 | $805.6M | $1.3B | ||
| Q4 24 | $824.3M | $1.3B | ||
| Q3 24 | $798.9M | $1.2B | ||
| Q2 24 | $784.8M | $1.2B | ||
| Q1 24 | $713.2M | $1.2B |
净利润CWRMD
| Q4 25 | $137.0M | $392.6M | ||
| Q3 25 | $124.8M | $348.5M | ||
| Q2 25 | $121.1M | $379.7M | ||
| Q1 25 | $101.3M | $365.0M | ||
| Q4 24 | $117.9M | $344.6M | ||
| Q3 24 | $111.2M | $311.4M | ||
| Q2 24 | $99.5M | $292.2M | ||
| Q1 24 | $76.5M | $300.5M |
毛利率CWRMD
| Q4 25 | 37.5% | 61.8% | ||
| Q3 25 | 37.7% | 61.5% | ||
| Q2 25 | 37.2% | 60.8% | ||
| Q1 25 | 36.3% | 59.3% | ||
| Q4 24 | 38.5% | 58.6% | ||
| Q3 24 | 37.3% | 58.6% | ||
| Q2 24 | 36.2% | 58.5% | ||
| Q1 24 | 35.6% | 57.9% |
营业利润率CWRMD
| Q4 25 | 19.2% | 34.6% | ||
| Q3 25 | 19.1% | 33.4% | ||
| Q2 25 | 17.8% | 33.7% | ||
| Q1 25 | 16.0% | 33.0% | ||
| Q4 24 | 18.8% | 32.5% | ||
| Q3 24 | 18.1% | 31.6% | ||
| Q2 24 | 16.4% | 31.2% | ||
| Q1 24 | 14.0% | 31.3% |
净利率CWRMD
| Q4 25 | 14.5% | 27.6% | ||
| Q3 25 | 14.4% | 26.1% | ||
| Q2 25 | 13.8% | 28.2% | ||
| Q1 25 | 12.6% | 28.3% | ||
| Q4 24 | 14.3% | 26.9% | ||
| Q3 24 | 13.9% | 25.4% | ||
| Q2 24 | 12.7% | 23.9% | ||
| Q1 24 | 10.7% | 25.1% |
每股收益（稀释后）CWRMD
| Q4 25 | $3.69 | $2.68 | ||
| Q3 25 | $3.31 | $2.37 | ||
| Q2 25 | $3.19 | $2.58 | ||
| Q1 25 | $2.68 | $2.48 | ||
| Q4 24 | $3.09 | $2.34 | ||
| Q3 24 | $2.89 | $2.11 | ||
| Q2 24 | $2.58 | $1.97 | ||
| Q1 24 | $1.99 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.4B |
| 总债务越低越好 | $957.9M | $403.9M |
| 股东权益账面价值 | $2.5B | $6.3B |
| 总资产 | $5.2B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.38× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资CWRMD
| Q4 25 | — | $1.4B | ||
| Q3 25 | — | $1.4B | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | $226.5M | $932.7M | ||
| Q4 24 | $385.0M | $521.9M | ||
| Q3 24 | — | $426.4M | ||
| Q2 24 | — | $238.4M | ||
| Q1 24 | $338.0M | $237.9M |
总债务CWRMD
| Q4 25 | $957.9M | $403.9M | ||
| Q3 25 | $968.6M | $408.7M | ||
| Q2 25 | $958.4M | $658.4M | ||
| Q1 25 | $958.6M | $663.1M | ||
| Q4 24 | $1.0B | $662.9M | ||
| Q3 24 | $1.0B | $667.6M | ||
| Q2 24 | $1.0B | $697.3M | ||
| Q1 24 | $1.1B | $997.0M |
股东权益CWRMD
| Q4 25 | $2.5B | $6.3B | ||
| Q3 25 | $2.5B | $6.1B | ||
| Q2 25 | $2.7B | $6.0B | ||
| Q1 25 | $2.6B | $5.5B | ||
| Q4 24 | $2.4B | $5.3B | ||
| Q3 24 | $2.5B | $5.2B | ||
| Q2 24 | $2.5B | $4.9B | ||
| Q1 24 | $2.4B | $4.6B |
总资产CWRMD
| Q4 25 | $5.2B | $8.5B | ||
| Q3 25 | $5.1B | $8.3B | ||
| Q2 25 | $5.2B | $8.2B | ||
| Q1 25 | $5.0B | $7.6B | ||
| Q4 24 | $5.0B | $7.1B | ||
| Q3 24 | $4.9B | $7.2B | ||
| Q2 24 | $4.7B | $6.9B | ||
| Q1 24 | $4.6B | $6.8B |
负债/权益比CWRMD
| Q4 25 | 0.38× | 0.06× | ||
| Q3 25 | 0.38× | 0.07× | ||
| Q2 25 | 0.35× | 0.11× | ||
| Q1 25 | 0.37× | 0.12× | ||
| Q4 24 | 0.43× | 0.13× | ||
| Q3 24 | 0.42× | 0.13× | ||
| Q2 24 | 0.43× | 0.14× | ||
| Q1 24 | 0.44× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $352.7M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | $315.1M | $311.2M |
| 自由现金流率自由现金流/营收 | 33.3% | 21.9% |
| 资本支出强度资本支出/营收 | 4.0% | 2.0% |
| 现金转化率经营现金流/净利润 | 2.57× | 0.87× |
| 过去12个月自由现金流最近4个季度 | $553.7M | $1.8B |
8季度趋势，按日历期对齐
经营现金流CWRMD
| Q4 25 | $352.7M | $339.7M | ||
| Q3 25 | $192.8M | $457.3M | ||
| Q2 25 | $136.6M | $538.8M | ||
| Q1 25 | $-38.8M | $578.7M | ||
| Q4 24 | $301.3M | $308.6M | ||
| Q3 24 | $177.3M | $325.5M | ||
| Q2 24 | $111.3M | $440.1M | ||
| Q1 24 | $-45.6M | $402.0M |
自由现金流CWRMD
| Q4 25 | $315.1M | $311.2M | ||
| Q3 25 | $175.9M | $414.4M | ||
| Q2 25 | $117.2M | $508.2M | ||
| Q1 25 | $-54.5M | $557.9M | ||
| Q4 24 | $278.0M | $288.0M | ||
| Q3 24 | $162.7M | $307.7M | ||
| Q2 24 | $100.3M | $415.2M | ||
| Q1 24 | $-57.7M | $380.8M |
自由现金流率CWRMD
| Q4 25 | 33.3% | 21.9% | ||
| Q3 25 | 20.2% | 31.0% | ||
| Q2 25 | 13.4% | 37.7% | ||
| Q1 25 | -6.8% | 43.2% | ||
| Q4 24 | 33.7% | 22.5% | ||
| Q3 24 | 20.4% | 25.1% | ||
| Q2 24 | 12.8% | 33.9% | ||
| Q1 24 | -8.1% | 31.8% |
资本支出强度CWRMD
| Q4 25 | 4.0% | 2.0% | ||
| Q3 25 | 1.9% | 3.2% | ||
| Q2 25 | 2.2% | 2.3% | ||
| Q1 25 | 2.0% | 1.6% | ||
| Q4 24 | 2.8% | 1.6% | ||
| Q3 24 | 1.8% | 1.5% | ||
| Q2 24 | 1.4% | 2.0% | ||
| Q1 24 | 1.7% | 1.8% |
现金转化率CWRMD
| Q4 25 | 2.57× | 0.87× | ||
| Q3 25 | 1.54× | 1.31× | ||
| Q2 25 | 1.13× | 1.42× | ||
| Q1 25 | -0.38× | 1.59× | ||
| Q4 24 | 2.56× | 0.90× | ||
| Q3 24 | 1.59× | 1.05× | ||
| Q2 24 | 1.12× | 1.51× | ||
| Q1 24 | -0.60× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CW
| Naval Power | $417.4M | 44% |
| Defense Electronics | $268.3M | 28% |
| Aerospace Industrial | $262.4M | 28% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
